{"id":"https://openalex.org/W4310127427","doi":"https://doi.org/10.1182/blood-2022-159983","title":"L-Mind: A Safety and Efficacy Analysis of Tafasitamab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Receiving Treatment for at Least 2 Years","display_name":"L-Mind: A Safety and Efficacy Analysis of Tafasitamab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Receiving Treatment for at Least 2 Years","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310127427","doi":"https://doi.org/10.1182/blood-2022-159983"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-159983","doi":"https://doi.org/10.1182/blood-2022-159983","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-159983","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061317839","display_name":"Johannes Duell","orcid":"https://orcid.org/0000-0001-6935-7997","observed_orcids":["https://orcid.org/0000-0001-6935-7997"]},"institutions":[{"id":"https://openalex.org/I4210126310","display_name":"Universit\u00e4tsklinikum W\u00fcrzburg","ror":"https://ror.org/03pvr2g57","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210126310"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Johannes Duell","raw_affiliation_strings":["1Medizinische Klinik und Poliklinik II, Universit\u00e4tsklinik W\u00fcrzburg, W\u00fcrzburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Medizinische Klinik und Poliklinik II, Universit\u00e4tsklinik W\u00fcrzburg, W\u00fcrzburg, Germany","institution_ids":["https://openalex.org/I4210126310"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102788725","display_name":"Wojciech J. Jurczak","orcid":"https://orcid.org/0000-0003-1879-8084","observed_orcids":["https://orcid.org/0000-0003-1879-8084"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wojciech Jurczak","raw_affiliation_strings":["2MSC National Research Institute of Oncology, Krakow, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MSC National Research Institute of Oncology, Krakow, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071466957","display_name":"Anna Marina Liberati","orcid":"https://orcid.org/0000-0002-3686-3188","observed_orcids":["https://orcid.org/0000-0002-3686-3188"]},"institutions":[{"id":"https://openalex.org/I27483092","display_name":"University of Perugia","ror":"https://ror.org/00x27da85","country_code":"IT","type":"education","lineage":["https://openalex.org/I27483092"]},{"id":"https://openalex.org/I4210123105","display_name":"Azienda Ospedaliera S.Maria","ror":"https://ror.org/02t96cy48","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210123105"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Anna Marina Liberati","raw_affiliation_strings":["3Universit\u00e0 degli Studi di Perugia, Azienda Ospedaliera Santa Maria di Terni, Terni, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Universit\u00e0 degli Studi di Perugia, Azienda Ospedaliera Santa Maria di Terni, Terni, Italy","institution_ids":["https://openalex.org/I27483092","https://openalex.org/I4210123105"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026128237","display_name":"Janusz Ha\u0142ka","orcid":"https://orcid.org/0000-0003-0493-6167","observed_orcids":["https://orcid.org/0000-0003-0493-6167"]},"institutions":[{"id":"https://openalex.org/I4210130748","display_name":"Ministry of Interior and Administration","ror":"https://ror.org/03c86nx70","country_code":"PL","type":"government","lineage":["https://openalex.org/I4210130748"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Janusz Halka","raw_affiliation_strings":["4Department of Hematology, Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration's Hospital, Olsztyn, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Hematology, Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration's Hospital, Olsztyn, Poland","institution_ids":["https://openalex.org/I4210130748"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008609643","display_name":"Esther Pena Carb\u00f3","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Esther Pena Carb\u00f3","raw_affiliation_strings":["5Department of Haematology, Navarra University Clinic, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Haematology, Navarra University Clinic, Pamplona, Spain","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007117385","display_name":"Pau Abrisqueta","orcid":"https://orcid.org/0000-0001-9625-7422","observed_orcids":["https://orcid.org/0000-0001-9625-7422","https://orcid.org/0000-0003-3028-7500"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Pau Abrisqueta Costa","raw_affiliation_strings":["6Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024389256","display_name":"Kami J. Maddocks","orcid":"https://orcid.org/0000-0001-8519-8404","observed_orcids":["https://orcid.org/0000-0001-8519-8404"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kami J. Maddocks","raw_affiliation_strings":["7Department of Internal Medicine, Arthur G James Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Department of Internal Medicine, Arthur G James Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, OH","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I2802841970","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046049357","display_name":"Martin H. Dreyling","orcid":"https://orcid.org/0000-0002-0358-5249","observed_orcids":["https://orcid.org/0000-0002-0358-5249"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Dreyling","raw_affiliation_strings":["8Ludwig-Maximilians-University Hospital, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Ludwig-Maximilians-University Hospital, Munich, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047622301","display_name":"Andreas Rosenwald","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25974101","display_name":"University of W\u00fcrzburg","ror":"https://ror.org/00fbnyb24","country_code":"DE","type":"education","lineage":["https://openalex.org/I25974101"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Rosenwald","raw_affiliation_strings":["9Department of Pathology, University of W\u00fcrzburg, W\u00fcrzburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Department of Pathology, University of W\u00fcrzburg, W\u00fcrzburg, Germany","institution_ids":["https://openalex.org/I25974101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036001420","display_name":"Abhishek Bakuli","orcid":"https://orcid.org/0000-0001-5123-1974","observed_orcids":["https://orcid.org/0000-0001-5123-1974"]},"institutions":[{"id":"https://openalex.org/I144094060","display_name":"MorphoSys (Germany)","ror":"https://ror.org/00ew7rg06","country_code":"DE","type":"company","lineage":["https://openalex.org/I144094060"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Abhishek Bakuli","raw_affiliation_strings":["10MorphoSys AG, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10MorphoSys AG, Planegg, Germany","institution_ids":["https://openalex.org/I144094060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011014349","display_name":"Aasim Amin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144094060","display_name":"MorphoSys (Germany)","ror":"https://ror.org/00ew7rg06","country_code":"DE","type":"company","lineage":["https://openalex.org/I144094060"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Aasim Amin","raw_affiliation_strings":["10MorphoSys AG, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10MorphoSys AG, Planegg, Germany","institution_ids":["https://openalex.org/I144094060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053541010","display_name":"Konstantin Gurbanov","orcid":"https://orcid.org/0009-0000-1191-6055","observed_orcids":["https://orcid.org/0009-0000-1191-6055"]},"institutions":[{"id":"https://openalex.org/I144094060","display_name":"MorphoSys (Germany)","ror":"https://ror.org/00ew7rg06","country_code":"DE","type":"company","lineage":["https://openalex.org/I144094060"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Konstantin Gurbanov","raw_affiliation_strings":["10MorphoSys AG, Planegg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10MorphoSys AG, Planegg, Germany","institution_ids":["https://openalex.org/I144094060"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086354986","display_name":"Gilles A. Salles","orcid":"https://orcid.org/0000-0002-9541-8666","observed_orcids":["https://orcid.org/0000-0002-9541-8666"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gilles Salles","raw_affiliation_strings":["11Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":14,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.232,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.56944832,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"140","issue":"Supplement 1","first_page":"6596","last_page":"6598"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tafasitamab","display_name":"tafasitamab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9449999928474426},{"id":"https://openalex.org/keywords/relapsed-refractory-diffuse-large-b-cell-lymphoma","display_name":"relapsed/refractory diffuse large B-cell lymphoma","score":0.9700000286102295},{"id":"https://openalex.org/keywords/anti-cd19-monoclonal-antibody","display_name":"anti-CD19 monoclonal antibody","score":0.921999990940094},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.6359999775886536},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.9139999747276306},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7580000162124634},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7440000176429749},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.5080000162124634},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.7829999923706055},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-phagocytosis","display_name":"antibody-dependent cellular phagocytosis","score":0.824999988079071}],"concepts":[{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.8237807154655457},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6565625667572021},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5657674074172974},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5589877367019653},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.558842658996582},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5564988851547241},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10366302728652954},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-159983","doi":"https://doi.org/10.1182/blood-2022-159983","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-159983","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3112732938","https://openalex.org/W3172444569","https://openalex.org/W4365514092","https://openalex.org/W4296468505","https://openalex.org/W4386271179","https://openalex.org/W4379334852","https://openalex.org/W4379979795","https://openalex.org/W4246296409","https://openalex.org/W2988395771","https://openalex.org/W4310163262"],"abstract_inverted_index":{"Introduction":[0],"Tafasitamab,":[1],"is":[2,99],"a":[3,100,208,439,444,450,534],"humanized,":[4],"Fc-modified":[5],"anti-CD19":[6],"monoclonal":[7],"antibody":[8],"that":[9,571,603],"functions":[10],"as":[11,443,454,626],"an":[12,184],"immunotherapy":[13,605],"through":[14],"direct":[15],"cytotoxicity":[16,20],"and":[17,22,59,66,88,137,158,183,253,283,329,360,390,399,447,477,531,551,610],"antibody-dependent":[18],"cellular":[19],"(ADCC)":[21],"phagocytosis":[23],"(ADCP).":[24],"Based":[25],"on":[26,150,211,231,374,416],"data":[27,139,260,601],"from":[28,85,629],"the":[29,56,63,71,104,266,270,330,337,457,461,470,500,512,545,556,572],"ongoing,":[30],"open-label,":[31],"multicenter,":[32],"single-arm,":[33],"Phase":[34],"II":[35],"L-MIND":[36,151],"study":[37,369],"(NCT02399085;":[38],"Salles,":[39],"et":[40,129],"al.":[41,130],"Lancet":[42],"Oncol":[43],"2020),":[44],"tafasitamab":[45,125,141,198,243,280,378,546,557,581,586,633,637],"in":[46,55,103,109,144,160,269,406,425,493,506,591,617],"combination":[47,560,630],"with":[48,76,146,171,207,555,580,593,635,645],"lenalidomide":[49,583],"(LEN)":[50],"was":[51,229,351,467,542],"granted":[52],"accelerated":[53],"approval":[54,61],"US":[57],"(2020)":[58],"conditional/accelerated":[60],"by":[62,357,456,585],"EMA":[64],"(2021)":[65],"other":[67],"regulatory":[68],"authorities":[69],"for":[70,92,113,124,140,155,162,295,326,343,377,397,408,432,518,597],"treatment":[72,154,249,294,325,342,422,431,517],"of":[73,191,197,214,234,265,279,303,411,473,499,525,540,568,612,623],"adult":[74],"patients":[75,145,241,268,275,285,304,322,339,372,403,428,484,503,514,592,627],"R/R":[77,147,173,529,594],"DLBCL":[78,83,148,595],"not":[79,480],"otherwise":[80],"specified,":[81],"including":[82],"arising":[84],"low-grade":[86],"lymphoma,":[87],"who":[89,152,305,314,323,340,429,515],"are":[90,347,414,505],"ineligible":[91,596],"autologous":[93],"stem":[94],"cell":[95],"transplant":[96],"(ASCT).":[97],"It":[98],"preferred":[101],"regimen":[102],"NCCN":[105],"Clinical":[106],"Practice":[107],"Guidelines":[108],"Oncology":[110,187],"(NCCN":[111],"Guidelines\u00ae)":[112],"this":[114,604,618],"setting.":[115],"We":[116],"have":[117,404,479],"previously":[118,437],"reported":[119,543],"long-term,":[120],"durable":[121,589],"clinical":[122],"activity":[123],"+":[126,142,281,558],"LEN":[127,143,225,282,287,559],"(Duell,":[128],"Haematologica":[131],"2021).":[132],"Here,":[133],"we":[134],"report":[135],"efficacy":[136],"safety":[138,254,648],"enrolled":[149],"received":[153,194,242,293,316,324,341,430,516],"\u22652":[156,296,327,344,381,433],"years":[157,170,297,328,382,614],"those":[159],"follow-up":[161,407,494,507],"\u22655":[163,409,519],"years.":[164],"Methods":[165],"Patients":[166,193],"were":[167,256,306,319,383,492,574],"aged":[168],"\u226518":[169],"ASCT-ineligible":[172],"DLBCL,":[174],"1-3":[175],"prior":[176,317],"systemic":[177],"therapies":[178],"(including":[179],"\u22651":[180],"CD20-targeting":[181],"regimen),":[182],"Eastern":[185],"Cooperative":[186],"Group":[188],"performance":[189],"status":[190],"0-2.":[192],"28-day":[195],"cycles":[196,278],"(12":[199],"mg/kg":[200],"IV),":[201],"once":[202],"weekly":[203],"during":[204,222,544],"Cycles":[205,223,235,552],"1-3,":[206],"loading":[209],"dose":[210],"Day":[212],"4":[213,284],"Cycle":[215,238],"1,":[216],"then":[217],"every":[218],"2":[219],"weeks":[220],"(Q2W)":[221],"4-12.":[224],"(25":[226],"mg":[227],"orally)":[228],"administered":[230],"Days":[232],"1-21":[233],"1-12.":[236],"After":[237],"12,":[239],"progression-free":[240,475],"Q2W":[244],"until":[245],"disease":[246,385],"progression.":[247],"Time-to-event,":[248],"response":[250,441,446,452],"(Cheson":[251],"2007),":[252],"endpoints":[255],"assessed.":[257],"Results":[258],"At":[259],"cut-off":[261],"(February":[262],"15,":[263],"2022),":[264],"81":[267],"full":[271,331],"analysis":[272,332],"set,":[273],"30":[274],"completed":[276],"12":[277,289],"discontinued":[286,421],"before":[288],"cycles;":[290],"27":[291,338],"(34%)":[292],"(median:":[298],"4.3":[299],"years).":[300],"The":[301,565,621],"proportion":[302],"primary":[307,501],"refractory,":[308],"refractory":[309,485,502],"to":[310,353,368,486,632,639],"previous":[311,487],"therapy,":[312],"or":[313,615],"had":[315,420,436,449,527,533],"ASCT":[318],"similar":[320],"between":[321],"set":[333],"(Table":[334],"1).":[335],"Of":[336,511],"years,":[345,410,434,520],"23":[346,435],"confirmed":[348],"alive,":[349],"one":[350,355,395,532],"lost":[352],"follow-up,":[354],"died":[356,362],"unknown":[358],"cause,":[359],"two":[361],"following":[363],"adverse":[364],"events":[365],"(AEs)":[366],"unrelated":[367],"treatment.":[370],"Thirteen":[371],"remained":[373],"treatment;":[375],"reasons":[376],"discontinuation":[379],"after":[380],"progressive":[384],"(n=4),":[386],"patient/physician":[387],"decision":[388],"(n=8),":[389],"non-treatment-related":[391],"fatal":[392],"AEs":[393,541,569,624],"(n=2:":[394],"each":[396],"COVID-19":[398],"cardiovascular":[400],"AE).":[401],"Twelve":[402],"been":[405,481],"whom":[412,526],"six":[413,513],"still":[415,424],"treatment,":[417],"while":[418],"6":[419],"although":[423],"response.":[426],"In":[427,483],"achieved":[438,522],"complete":[440],"(CR)":[442],"best":[445],"four":[448],"partial":[451],"(PR),":[453],"assessed":[455],"investigator":[458],"(Figure":[459],"1);":[460],"48-month":[462],"overall":[463],"survival":[464,611],"(OS)":[465],"rate":[466],"92.6%;":[468],"however,":[469],"median":[471],"duration":[472],"response,":[474],"survival,":[476],"OS":[478],"reached.":[482],"therapy":[488,561,579,631],"line":[489],"(n=12),":[490],"91.7%":[491],"at":[495,508],"48":[496],"months.":[497,510],"All":[498],"(n=4)":[504],"60":[509,640],"five":[521],"CR":[523],"(one":[524],"triple-hit":[528],"DLBCL)":[530],"PR":[535],"(investigator-assessed).":[536],"A":[537],"lower":[538],"incidence":[539,567,622],"monotherapy":[547,587],"phase":[548,562],"(Cycles":[549,563],"13-24":[550],"\u226525)":[553],"compared":[554],"1-12).":[564],"exposure-adjusted":[566],"showed":[570],"majority":[573],"Grade":[575],"1-2.":[576],"Conclusion":[577],"Combination":[578],"plus":[582],"followed":[584],"provided":[588],"responses":[590],"ASCT.":[598],"These":[599],"long-term":[600,636],"suggest":[602],"can":[606],"achieve":[607],"prolonged":[608],"remission":[609],"5":[613],"longer":[616],"patient":[619],"population.":[620],"decreased":[625],"transitioned":[628],"monotherapy,":[634],"(up":[638],"months)":[641],"being":[642],"well":[643],"tolerated":[644],"no":[646],"new":[647],"signals.":[649],"Funding":[650],"MorphoSys":[651],"AG":[652],"Figure":[653],"1View":[654,657],"largeDownload":[655,658],"PPTFigure":[656],"PPT":[659],"Close":[660],"modal":[661]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2022-11-30T00:00:00"}